Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Bavarian Nordic ADR (OP:BVNRY)

9.926 +0.066 (+0.67%)
Streaming Delayed Price Updated: 3:51 PM EST, Dec 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Bavarian Nordic ADR

< Previous 1 2 3 Next >
News headline image
UK Secures Additional Doses Of Bavarian Nordic Mpox Vaccine To Combat New Variant Threat ↗
The UK government has purchased 150,000 mpox vaccine doses from Bavarian Nordic, enhancing its response to clade I mpox, while partnering with WHO and UNICEF. 
Via Benzinga
News headline image
Moderna's Investigational Mpox Vaccine More Effective Than Current Approved Shot, Animal Study Shows ↗
Moderna is conducting a Phase 1/2 trial of mRNA-1769, a potential mpox vaccine for adults. Early research shows it may outperform Bavarian Nordic's Jynneos in reducing severe disease in monkeys. 
Via Benzinga
News headline image
Mpox Vaccines: Challenges Persist as Congo Receives First Batch Of Doses Almost 2 Years After It Declared Epidemic ↗
The European Commission's first delivery of mpox vaccines to Congo aims to combat the outbreak, despite challenges in distribution and approval. 
Via Benzinga
News headline image
WHO Seeks $135M In Funding To Fight Mpox: Outbreak 'Can Be Controlled, And Can Be Stopped' ↗
To fight the mpox outbreak in Africa, the World Health Organization calls for funding help for its six-month plan. 
Via Benzinga
News headline image
Diagnostic Giants Labcorp, Roche To Ramp Up Testing Capacity Amid Global Concerns Over New Mpox Strain ↗
Labcorp considers boosting its mpox testing capacity as the WHO declares a global health emergency. Companies like Roche and Quest Diagnostics are also monitoring demand and expanding testing... 
Via Benzinga
News headline image
Bavarian Nordic Recruits US Firm For Packaging Services For Its Monkeypox Vaccine ↗
 
Via Benzinga
News headline image
3 Promising Vaccine Stocks To Watch In The Event Of A Mpox Surge ↗
Mpox rerun is making these stocks soar. But a non-vaccine approach could yield greater gains. 
Via Talk Markets
News headline image
Mpox Variant Sparks Global Concern As Europe, China Ramp Up Screening ↗
Increased screening for deadly new version of mpox is seen in Europe and China. More imported cases are expected. New vaccines are being developed. 
Via Benzinga
News headline image
Mpox Vaccine Maker Bavarian Nordic Targets Broader Access With European Submission For Imvanex Adolescent Use During WHO Emergency ↗
Bavarian Nordic submits data to European Medicines Agency seeking approval to extend Imvanex vaccine use to adolescents. New trials in younger children planned as global demand for smallpox and mpox... 
Via Benzinga
News headline image
Emergent Biosolutions, Bavarian Nordic, GeoVax And SIGA Technologies Shares Are Making Big Moves Thursday: What's Going On? ↗
Several healthcare stocks associated with mpox are seeing increased attention Thursday after the World Health Organization declared a public health emergency in response to an mpox outbreak in Africa. 
Via Benzinga
News headline image
WHO Declares Mpox Public Health Emergency: 'Coordinated International Response Essential' To Halt Outbreak ↗
A public health emergency for mpox in Africa saw vaccine stocks jump Wednesday. A look at the stocks and what's next for fighting the virus. 
Via Benzinga
News headline image
Bavarian Nordic Beefs Up Chikungunya Vaccine Race With Valneva With Encouraging Late-Stage Trial Data ↗
Bavarian Nordic A/S's (OTC: BVNRY) phase 3 chikungunya virus vaccine (CHIKV VLP (PXVX0317) clinical trial has hit its primary endpoint in  
Via Benzinga
News headline image
Monkeypox Vaccine Maker Bavarian Nordic Bets $380M On Emergent Bio's Travel Vaccines ↗
 
Via Benzinga
News headline image
West Africa-Based Studies Show JNJ, Merck's Ebola Vaccines Provide Lasting Antibodies ↗
 
Via Benzinga
News headline image
Threats For New Outbreak Looms, As Scientists Signal Deadly Monkeypox Variant Circulating In Central Africa ↗
Researchers have warned that a dangerous monkeypox variant with a fatality rate as high as 10% is circulating in Central Africa, which could trigger new global outbreaks. After analyzing 1,463 cases... 
Via Benzinga
News headline image
White House May Ask For $25B Emergency Funding For COVID-19, Monkeypox ↗
 
Via Benzinga
News headline image
Is Monkeypox Outbreak Cooling? Health Officials Says Virus Transmission Has Slowed ↗
 
Via Benzinga
News headline image
SIGA Tech Made The Smallpox Treatment As Post-9/11 Bioterrorism Defense: Report ↗
In an effort to prevent bioterrorism attacks, just in case, SIGA Technologies Inc (NASDAQ: SIGA) started working on the smallpox treatment, Tpoxx, after the 9/11 terrorist attack that shook the world.... 
Via Benzinga
News headline image
3 Top Monkeypox Stocks to Buy Right Now ↗
With cases of a frightening disease spreading to all 50 states, it’s now time to consider the top monkeypox stocks to buy right now. 
Via InvestorPlace
News headline image
PTON Stock Pops as Peloton Products Launch on Amazon ↗
Peloton (PTON) stock is getting a boost on Wednesday after the fitness company's products started selling on Amazon (AMZN). 
Via InvestorPlace
News headline image
BVNRY Stock Alert: What to Know as Bavarian Nordic Signs Supply Agreement ↗
Bavarian Nordic (BVNRY) stock is on the move Wednesday after the monkeypox vaccine company signed a supply agreement with PAHO. 
Via InvestorPlace
News headline image
Benzinga Before The Bell: Top Amazon Seller Succumbs To Economic Meltdown, Twitter To Tackle Toxic Content, Spam Bots, Bed Bath & Beyond Secures Loan Deal As It Tries To Stay Afloat And Other Top Financial Stories Wednesday, August 24 ↗
CNBC Top Amazon Seller Succumbs To Economic Meltdown 
Via Benzinga
News headline image
Bavarian Nordic Making All Efforts To Stretch Capacity To Boost Monkeypox Vaccine Supplies ↗
Bavarian Nordic A/S (OTC: BVNRY) said it was making "every effort" to meet the high demand for its monkeypox vaccine worldwide as it kept its business outlook for the year. 
Via Benzinga
News headline image
Experts Cast Doubt On Dependence On Monkeypox Vaccine Amid Limited Trial Data, Supply Crunch ↗
The only FDA-approved monkeypox vaccine from Bavarian Nordic A/S (OTC: BVNY) is in short supply. 
Via Benzinga
News headline image
Applied DNA Seeks Approval For PCR-Based Monkeypox Virus Test ↗
 
Via Benzinga
News headline image
Biden Officials Seek To Boost Supply For Monkeypox Vaccines, Treatment ↗
Top Biden administration officials are poised to lay out new steps to accelerate the U.S. response amid the spread of monkeypox and demand for vaccines & treatments. 
Via Benzinga
News headline image
7 Monkeypox Vaccine Stocks to Buy Before They Shoot Higher ↗
These monkeypox stocks could be among the best choices to buy in August. Each can make great investments as government responses ramp up. 
Via InvestorPlace
News headline image
The Only Monkeypox Vaccine Maker Finds It Difficult To Meet Accelerating Demand ↗
Bavarian Nordic A/S (OTC: BVNKF), the only company with an approved vaccine for monkeypox, said it’s no longer sure it can meet demand as cases continue to rise worldwide, 
Via Benzinga
News headline image
Plan To Extend Supply Of Monkeypox Vaccine On Cusp Of Emergency Clearance: Report ↗
A plan to extend the limited supply of monkeypox vaccine in order to provide additional doses may soon be receiving emergency clearance by U.S. health officials. 
Via Benzinga
News headline image
3 Monkeypox Stocks to Buy as Biden Declares Public Health Emergency ↗
Monkeypox stocks are about to rise now that the White House has declared the virus a public health emergency. Here are the stocks to watch. 
Via InvestorPlace
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.